Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2026-03-08 @ 11:00 PM
Study NCT ID:
NCT00595335
Status:
COMPLETED
Last Update Posted:
2016-01-01
First Post:
2008-01-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial of Rituximab for Graves' Ophthalmopathy
Sponsor:
Rebecca Bahn
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
06-006130
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None